<p>Grb2 contrast increase upon EGF stimulation (170 nM, 15 min) in cells pre-incubated with the indicated EGFR antagonists for 4 hours in comparison to untreated cells. Error bars are based on the standard error of the mean (n = 40 cells).</p
<p>Asterisk (*) denotes statistical significance (p<0.05) of a signal compared to that from the untr...
<p>(<b>A</b>) Serum-starved H292 cells were pre-treated for 1 h with DMSO vehicle or the indicated c...
<p>Cells were treated with cisplatin or eribulin for 72 h, and then cell viability was determined by...
<p>(A) HeLa cells expressing EGFR-GFP or Grb2-YFP, respectively, grown on anti-EGFR antibody coated ...
<p>(A) Representative HeLa cell expressing Grb2-YFP grown on an anti-EGFR antibody coated μ-biochip....
<p>(A) EGF increased the rate of sphere formation in a dose-dependent fashion in 22B and HN-1 cells,...
<p>(A) Treament with 20 ng/ml EGF induced the expression of CD44, BMI-1, Oct-4, Nanog, CXCR4 and SDF...
<p><i>A</i>. Serum-starved A431 cells were treated with 0 nM, 0.5 nM or 16 nM EGF. At the indicated ...
<p>A – D, serum-starved cells were stimulated with EGF for 5 min and probed by western blot for the ...
<p>Live HEK293FT cells were treated with 20 nM agonist followed by increasing concentrations of AG-1...
<p>C4–12/Flag.ERβ cells were treated with 10 nM E2 for 3 days. Cell confluency, detected by the Incu...
<p>Serum-starved A431 cells were treated with either 1 nM or 32 nM EGF. Phosphorylation of EGFR and ...
<p>HEK293FT cells were treated with 1 µM EGF or HRG. Cells expressing EGFR/Rluc8, Grb2/Venus and HER...
<p>HEK293FT cells expressing EGFR/Rluc8 and Grb2/Venus, with and without HER3, were treated with inc...
<p>HEK293FT cells were treated with 20 nM agonist followed by 1 µM AG-1478 or vehicle (control) afte...
<p>Asterisk (*) denotes statistical significance (p<0.05) of a signal compared to that from the untr...
<p>(<b>A</b>) Serum-starved H292 cells were pre-treated for 1 h with DMSO vehicle or the indicated c...
<p>Cells were treated with cisplatin or eribulin for 72 h, and then cell viability was determined by...
<p>(A) HeLa cells expressing EGFR-GFP or Grb2-YFP, respectively, grown on anti-EGFR antibody coated ...
<p>(A) Representative HeLa cell expressing Grb2-YFP grown on an anti-EGFR antibody coated μ-biochip....
<p>(A) EGF increased the rate of sphere formation in a dose-dependent fashion in 22B and HN-1 cells,...
<p>(A) Treament with 20 ng/ml EGF induced the expression of CD44, BMI-1, Oct-4, Nanog, CXCR4 and SDF...
<p><i>A</i>. Serum-starved A431 cells were treated with 0 nM, 0.5 nM or 16 nM EGF. At the indicated ...
<p>A – D, serum-starved cells were stimulated with EGF for 5 min and probed by western blot for the ...
<p>Live HEK293FT cells were treated with 20 nM agonist followed by increasing concentrations of AG-1...
<p>C4–12/Flag.ERβ cells were treated with 10 nM E2 for 3 days. Cell confluency, detected by the Incu...
<p>Serum-starved A431 cells were treated with either 1 nM or 32 nM EGF. Phosphorylation of EGFR and ...
<p>HEK293FT cells were treated with 1 µM EGF or HRG. Cells expressing EGFR/Rluc8, Grb2/Venus and HER...
<p>HEK293FT cells expressing EGFR/Rluc8 and Grb2/Venus, with and without HER3, were treated with inc...
<p>HEK293FT cells were treated with 20 nM agonist followed by 1 µM AG-1478 or vehicle (control) afte...
<p>Asterisk (*) denotes statistical significance (p<0.05) of a signal compared to that from the untr...
<p>(<b>A</b>) Serum-starved H292 cells were pre-treated for 1 h with DMSO vehicle or the indicated c...
<p>Cells were treated with cisplatin or eribulin for 72 h, and then cell viability was determined by...